Syngene International, a global research, development and biotech pharmaceutical manufacturing company, will be establishing its first U.S. facility in Baltimore City, Gov. Wes Moore‘s office ...

Monoclonal antibodies (mAbs) have revolutionized modern medicine, offering precision therapies for cancer, autoimmune disorders, infectious diseases, and numerous other advantages. The global mAb ...

Johnson & Johnson expands its Tar Heel State presence with $2 billion investment, and Syngene sites first U.S. facility in Baltimore. Johnson & Johnson is expanding its footprint in North Carolina ...

Syngene posted its financials for the third quarter on 22 January, with revenue and profit missing estimates.(AFP) Contract drug research and manufacturing firm Syngene International Ltd has lowered ...

The global Highly Potent Active Pharmaceutical Ingredients (HPAPI) Market is projected to expand at a robust CAGR of around 9% over the next five years, driven by the increasing incidence of cancer ...

DUBLIN--(BUSINESS WIRE)--The "Cytotoxic Drugs & HPAPI Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Product, Company Size, Scale of Operation, Type of Molecule, Type of ...